{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":11643,"items":[{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:53:33Z","timestamp":1694631213295},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T00:00:00Z","timestamp":1202342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T00:00:00Z","timestamp":1202342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/sj.leu.2405103","type":"journal-article","created":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T10:54:03Z","timestamp":1202381643000},"page":"1469-1472","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic and molecular switching in relapsed acute promyelocytic leukemia"],"prefix":"10.1038","volume":"22","author":[{"given":"F","family":"Albano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Pannunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Anelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Zagaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Liso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Specchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,7]]},"reference":[{"key":"BF2405103_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-2141.1999.01501.x","volume":"106","author":"D Grimwade","year":"1999","unstructured":"Grimwade D . The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. Br J Haematol 1999; 106: 591\u2013613.","journal-title":"Br J Haematol"},{"key":"BF2405103_CR2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V86.4.1540.bloodjournal8641540","volume":"86","author":"RE Gallagher","year":"1995","unstructured":"Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P et al. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break\/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood 1995; 86: 1540\u20131547.","journal-title":"Blood"},{"key":"BF2405103_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/j.1460-2075.1992.tb05185.x","volume":"11","author":"PP Pandolfi","year":"1992","unstructured":"Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D et al. Genomic variability and alternative splicing generate multiple PML\/RAR alpha transcripts that encode aberrant PML proteins and PML\/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J 1992; 11: 1397\u20131407.","journal-title":"EMBO J"},{"key":"BF2405103_CR4","first-page":"1014","volume":"90","author":"F Mandelli","year":"1997","unstructured":"Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. Molecular remission in PML\/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997; 90: 1014\u20131021.","journal-title":"Blood"},{"key":"BF2405103_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cancergencyto.2007.03.013","volume":"176","author":"K Miyazaki","year":"2007","unstructured":"Miyazaki K, Kikukawa M, Kiuchi A, Shin K, Iwamoto T, Ohyashiki K . Complex translocations derived stepwise from standard t(15;17) in a patient with variant acute promyelocytic leukemia. Cancer Genet Cytogenet 2007; 176: 127\u2013130.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2405103_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/sj.leu.2402205","volume":"15","author":"L Xu","year":"2001","unstructured":"Xu L, Zhao WL, Xiong SM, Su XY, Zhao M, Wang C et al. Molecular cytogenetic characterization and clinical relevance of additional, complex and\/or variant chromosome abnormalities in acute promyelocytic leukemia. Leukemia 2001; 15: 1359\u20131368.","journal-title":"Leukemia"},{"key":"BF2405103_CR7","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1038\/sj.onc.1204765","volume":"20","author":"K Jensen","year":"2001","unstructured":"Jensen K, Shiels C, Freemont PS . PML protein isoforms and the RBCC\/TRIM motif. Oncogene 2001; 20: 7223\u20137233.","journal-title":"Oncogene"},{"key":"BF2405103_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/sj.leu.2404246","volume":"20","author":"J Cloos","year":"2006","unstructured":"Cloos J, Goemans BF, Hess CJ, van Oostveen JW, Waisfisz Q, Corthals S et al. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Leukemia 2006; 20: 1217\u20131220.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2405103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405103","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:18:31Z","timestamp":1648779511000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2405103"}},"issued":{"date-parts":[[2008,2,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BF2405103"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2405103","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2008,2,7]]},"assertion":[{"value":"7 February 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T15:02:30Z","timestamp":1700578950746},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T00:00:00Z","timestamp":1212624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T00:00:00Z","timestamp":1212624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/leu.2008.139","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T11:24:51Z","timestamp":1212665091000},"page":"2277-2278","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy"],"prefix":"10.1038","volume":"22","author":[{"given":"R","family":"Swords","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"O'Rafferty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,5]]},"reference":[{"key":"BFleu2008139_CR1","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1200\/JCO.1993.11.11.2186","volume":"11","author":"S Kim","year":"1993","unstructured":"Kim S, Chatelut E, Kim JC, Howell SB, Cates C, Kormanik PA et al. Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 1993; 11: 2186\u20132193.","journal-title":"J Clin Oncol"},{"key":"BFleu2008139_CR2","first-page":"10","volume":"6","author":"S Howell","year":"2003","unstructured":"Howell S . Liposomal cytarabine for the treatment of lymphomatous meningitis. Biol Ther Lymph 2003; 6: 10\u201314.","journal-title":"Biol Ther Lymph"},{"key":"BFleu2008139_CR3","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, Shapiro W, Swinnen L, Rozental JR et al. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999; 17: 3110\u20133116.","journal-title":"J Clin Oncol"},{"key":"BFleu2008139_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1023\/A:1015752331041","volume":"57","author":"KA Jaeckle","year":"2002","unstructured":"Jaeckle KA, Batchelor T, O'Day SJ, Phuphanich S, New P, Lesser G et al. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol 2002; 57: 231\u2013239.","journal-title":"J Neurooncol"},{"key":"BFleu2008139_CR5","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood-2006-08-043646","volume":"109","author":"E Jabbour","year":"2007","unstructured":"Jabbour E, O'Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F et al. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood 2007; 109: 3214\u20133218.","journal-title":"Blood"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2008139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:16:15Z","timestamp":1648725375000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2008139"}},"issued":{"date-parts":[[2008,6,5]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFleu2008139"],"URL":"https:\/\/doi.org\/10.1038\/leu.2008.139","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2008,6,5]]},"assertion":[{"value":"5 June 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:55:08Z","timestamp":1740167708238,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41375-020-0984-9","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T18:04:24Z","timestamp":1594922664000},"page":"2837-2839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["From leeches to interferon: should cytoreduction be prescribed for all patients with polycythemia vera?"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8121-438X","authenticated-orcid":false,"given":"Jean-Jacques","family":"Kiladjian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziano","family":"Barbui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"984_CR1","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1200\/JCO.2011.36.0792","volume":"29","author":"JJ Kiladjian","year":"2011","unstructured":"Kiladjian JJ, Chevret S, Dosquet C, Chomienne C, Rain JD. Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980. J Clin Oncol. 2011;29:3907\u201313.","journal-title":"J Clin Oncol"},{"key":"984_CR2","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1182\/blood-2004-09-3426","volume":"105","author":"G Finazzi","year":"2005","unstructured":"Finazzi G, Caruso V, Marchioli R, Capnist G, Chisesi T, Finelli C, et al. Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood. 2005;105:2664\u201370.","journal-title":"Blood."},{"key":"984_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1056\/NEJMoa035572","volume":"350","author":"R Landolfi","year":"2004","unstructured":"Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N. Engl J Med. 2004;350:114\u201324.","journal-title":"N. Engl J Med"},{"key":"984_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41375-018-0077-1","volume":"32","author":"T Barbui","year":"2018","unstructured":"Barbui T, Tefferi A, Vannucchi AM, Passamonti F, Silver RT, Hoffman R, et al. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. Leukemia. 2018;32:1057\u201369.","journal-title":"Leukemia."},{"key":"984_CR5","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.3324\/haematol.2019.221234","volume":"104","author":"A Ferrari","year":"2019","unstructured":"Ferrari A, Carobbio A, Masciulli A, Ghirardi A, Finazzi G, De Stefano V, et al. Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis. Haematologica. 2019;104:2391\u20139.","journal-title":"Haematologica."},{"key":"984_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00277-019-03625-x","volume":"98","author":"M Griesshammer","year":"2019","unstructured":"Griesshammer M, Kiladjian JJ, Besses C. Thromboembolic events in polycythemia vera. Ann Hematol. 2019;98:1071\u201382.","journal-title":"Ann Hematol."},{"key":"984_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/M17-0028","volume":"168","author":"M Hultcrantz","year":"2018","unstructured":"Hultcrantz M, Bj\u00f6rkholm M, Dickman PW, Landgren O, Derolf \u00c5, Kristinsson SY, et al. Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study. Ann Intern Med. 2018;168:317\u201325.","journal-title":"Ann Intern Med"},{"key":"984_CR8","first-page":"895","volume":"377","author":"JL Spivak","year":"2017","unstructured":"Spivak JL. Myeloproliferative neoplasms. N. Engl J Med. 2017;377:895\u20136.","journal-title":"N. Engl J Med"},{"key":"984_CR9","first-page":"17","volume":"34","author":"SM Fruchtman","year":"1997","unstructured":"Fruchtman SM, Mack K, Kaplan ME, Peterson P, Berk PD, Wasserman LR. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Semin Hematol 1997;34:17\u201323.","journal-title":"Semin Hematol"},{"key":"984_CR10","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","volume":"30","author":"RM Emanuel","year":"2012","unstructured":"Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, et al. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol. 2012;30:4098\u2013103.","journal-title":"J Clin Oncol"},{"key":"984_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1200\/JCO.2015.62.9337","volume":"34","author":"H Geyer","year":"2016","unstructured":"Geyer H, Scherber R, Kosiorek H, Dueck AC, Kiladjian JJ, Xiao Z, et al. Symptomatic profiles of patients with polycythemia vera: implications of inadequately controlled disease. J Clin Oncol. 2016;34:151\u20139.","journal-title":"J Clin Oncol"},{"key":"984_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2141.1994.tb03289.x","volume":"86","author":"Y Najean","year":"1994","unstructured":"Najean Y, Dresch C, Rain JD. The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group. Br J Haematol. 1994;86:233\u20135.","journal-title":"Br J Haematol"},{"key":"984_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1208500","volume":"368","author":"R Marchioli","year":"2013","unstructured":"Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, et al. Cardiovascular events and intensity of treatment in polycythemia vera. N. Engl J Med. 2013;368:22\u201333.","journal-title":"N. Engl J Med"},{"key":"984_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1182\/blood.2018834044","volume":"134","author":"JL Spivak","year":"2019","unstructured":"Spivak JL. How I treat polycythemia vera. Blood. 2019;134:341\u201352.","journal-title":"Blood."},{"key":"984_CR15","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","volume":"112","author":"JJ Kiladjian","year":"2008","unstructured":"Kiladjian JJ, Cassinat B, Chevret S, Turlure P, Cambier N, Roussel M, et al. Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. Blood. 2008;112:3065\u201372.","journal-title":"Blood."},{"key":"984_CR16","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1200\/JCO.2009.23.6075","volume":"27","author":"A Quint\u00e1s-Cardama","year":"2009","unstructured":"Quint\u00e1s-Cardama A, Kantarjian H, Manshouri T, Luthra R, Estrov Z, Pierce S, et al. Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera. J Clin Oncol. 2009;27:5418\u201324.","journal-title":"J Clin Oncol"},{"key":"984_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/leu.2015.326","volume":"30","author":"JJ Kiladjian","year":"2016","unstructured":"Kiladjian JJ, Giraudier S, Cassinat B. Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone. Leukemia. 2016;30:776\u201381.","journal-title":"Leukemia."},{"key":"984_CR18","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/S2352-3026(17)30039-X","volume":"4","author":"JJ Kiladjian","year":"2017","unstructured":"Kiladjian JJ. Long-term treatment with interferon alfa for myeloproliferative neoplasms. Lancet Haematol. 2017;4:e150\u2013e1.","journal-title":"Lancet Haematol"},{"key":"984_CR19","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1182\/blood.2019000428","volume":"134","author":"A Yacoub","year":"2019","unstructured":"Yacoub A, Mascarenhas J, Kosiorek H, Prchal JT, Berenzon D, Baer MR, et al. Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea. Blood. 2019;134:1498\u2013509.","journal-title":"Blood."},{"key":"984_CR20","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1038\/s41375-019-0524-7","volume":"33","author":"J Mascarenhas","year":"2019","unstructured":"Mascarenhas J, Kosiorek H, Prchal J, Yacoub A, Berenzon D, Baer MR, et al. A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. Leukemia. 2019;33:2974\u20138.","journal-title":"Leukemia."},{"key":"984_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0140-6736(88)92881-4","volume":"2","author":"RT Silver","year":"1988","unstructured":"Silver RT. Recombinant interferon-alpha for treatment of polycythaemia vera. Lancet. 1988;2:403.","journal-title":"Lancet."},{"key":"984_CR22","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/S2352-3026(19)30236-4","volume":"7","author":"H Gisslinger","year":"2020","unstructured":"Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, et al. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study. Lancet Haematol. 2020;7:e196\u2013e208.","journal-title":"Lancet Haematol"},{"key":"984_CR23","doi-asserted-by":"crossref","unstructured":"Gisslinger H, Zagrijtschuk O, Buxhofer-Ausch V, Thaler J, Schloegl E, Gastl GA, et al. Ropeginterferon alfa-2b, a novel IFN\u03b1-2b, induces high response rates with low toxicity in patients with polycythemia vera. Blood. 2015;126(15):1762\u20139.","DOI":"10.1182\/blood-2015-04-637280"},{"issue":"Suppl 1","key":"984_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/blood-2019-122233","volume":"134","author":"J-J Kiladjian","year":"2019","unstructured":"Kiladjian J-J, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, et al. Thromboembolic risk reduction and high rate of complete molecular response with long-term use of ropeginterferon alpha-2b in polycythemia vera: results from a randomized controlled study. Blood. 2019;134 Suppl 1:553.","journal-title":"Blood."},{"issue":"10","key":"984_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.6004\/jnccn.2017.0157","volume":"15","author":"J-J Kiladjian","year":"2017","unstructured":"Mesa RA, Jamieson C, Bhatia R, Deininger MW, Fletcher CD, Gerds AT, et al. NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018. J Natl Compr Canc Netw. 2017;15(10):1193\u2013207.","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"984_CR26","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","volume":"3","author":"A Carobbio","year":"2019","unstructured":"Carobbio A, Ferrari A, Masciulli A, Ghirardi A, Barosi G, Barbui T. Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis. Blood Adv. 2019;3(11):1729\u201337.","journal-title":"Blood Adv"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0984-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0984-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0984-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:41:42Z","timestamp":1684618902000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0984-9"}},"issued":{"date-parts":[[2020,7,16]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-0984-9","ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"20 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JJK served in advisory boards for Novartis, AOP Orphan, BMS. TB served in advisory boards for Novartis, AOP Orphan, Italfarmaco.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]},{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T09:56:26Z","timestamp":1783850186074,"version":"3.55.0"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[1997,9,1]]},"DOI":"10.1038\/sj.leu.2400772","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:20:00Z","timestamp":1031163600000},"page":"1501-1507","source":"Crossref","is-referenced-by-count":38,"title":["Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications"],"prefix":"10.1038","volume":"11","author":[{"given":"C","family":"Guglielmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Cordone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Boecklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"Vegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Testi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Foa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2400772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2400772","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2400772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:05:44Z","timestamp":1648753544000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2400772"}},"issued":{"date-parts":[[1997,9,1]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,9,1]]}},"alternative-id":["BF2400772"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2400772","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[1997,9,1]]}},{"indexed":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T01:03:05Z","timestamp":1706144585662},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,8,1]]},"DOI":"10.1038\/s41375-020-0744-x","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T18:03:46Z","timestamp":1581703426000},"page":"2220-2224","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia"],"prefix":"10.1038","volume":"34","author":[{"given":"Adil S. A.","family":"Al Hinai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Grob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois G.","family":"Kavelaars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelieke","family":"Zeilemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia A. J.","family":"Erpelinck-Verschueren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten J.","family":"Gussinklo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathijs A.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"van Lom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J. M.","family":"Valk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"744_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"744_CR2","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson AG, et al. Genomic and epigenomic landscapes of Adult De Novo Acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med"},{"key":"744_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood-2015-07-604496","volume":"127","author":"D Grimwade","year":"2016","unstructured":"Grimwade D, Ivey A, Huntly BJP. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 2016;127:29\u201341.","journal-title":"Blood"},{"key":"744_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111\u201321.","journal-title":"N Engl J Med"},{"key":"744_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1182\/blood-2017-07-746453","volume":"131","author":"LI Shlush","year":"2018","unstructured":"Shlush LI. Age-related clonal hematopoiesis. Blood. 2018;131:496\u2013504.","journal-title":"Blood"},{"key":"744_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481:506\u201310.","journal-title":"Nature"},{"key":"744_CR7","doi-asserted-by":"crossref","unstructured":"Yilmaz M, Wang F, Loghavi S, Bueso-Ramos C, Gumbs C, Little L, et al. Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia? Blood Cancer J. 2019;9:7.","DOI":"10.1038\/s41408-019-0170-3"},{"key":"744_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00277-014-2248-0","volume":"94","author":"N Xu","year":"2015","unstructured":"Xu N, Ding L, Yin C, Zhou X, Li L, Li Y, et al. A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients. Ann Hematol. 2015;94:865\u20137.","journal-title":"Ann Hematol"},{"key":"744_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12288-016-0658-y","volume":"32","author":"M Rashid","year":"2016","unstructured":"Rashid M, Ahmed RZ, Ahmed S, Nadeem M, Ahmed N, Shamsi TS. Coexisting JAK2V617F and CALR Exon 9 mutation in essential thrombocythemia. Indian J Hematol Blood Transfus. 2016;32:112\u20136.","journal-title":"Indian J Hematol Blood Transfus"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0744-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T18:02:57Z","timestamp":1705082577000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0744-x"}},"issued":{"date-parts":[[2020,2,14]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,1]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-0744-x","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"24 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]},{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:02:12Z","timestamp":1694620932770},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1038\/sj.leu.2402562","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T10:59:36Z","timestamp":1035197976000},"page":"1575-1576","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to Andersson and Fioretos"],"prefix":"10.1038","volume":"16","author":[{"given":"M","family":"Dupont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,7,31]]},"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402562","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:35:10Z","timestamp":1648762510000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402562"}},"issued":{"date-parts":[[2002,7,31]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["BF2402562"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402562","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2002,7,31]]},"assertion":[{"value":"31 July 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:56:43Z","timestamp":1722963403990},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/leu.2012.259","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T06:42:55Z","timestamp":1346827375000},"page":"971-974","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment patterns and outcomes in elderly patients with multiple myeloma"],"prefix":"10.1038","volume":"27","author":[{"given":"S-M","family":"Bang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S V","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"BFleu2012259_CR1","unstructured":"Median age of cancer patients at diagnosis, 2003\u20132007 by primary cancer site, race and sex (http:\/\/seer.cancer.gov\/csr\/1975_2007\/results_single\/sect_01_table.11_2pgs.pdf)."},{"key":"BFleu2012259_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2141.2004.05207.x","volume":"127","author":"KJ Phekoo","year":"2004","unstructured":"Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillett D et al. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol 2004; 127: 299\u2013304.","journal-title":"Br J Haematol"},{"key":"BFleu2012259_CR3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bjorkholm M . Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 2007; 25: 1993\u20131999.","journal-title":"J Clin Oncol"},{"key":"BFleu2012259_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/1097-0142(19900901)66:5<965::AID-CNCR2820660526>3.0.CO;2-M","volume":"66","author":"P Froom","year":"1990","unstructured":"Froom P, Quitt M, Aghai E . Multiple myeloma in the geriatric patient. Cancer 1990; 66: 965\u2013967.","journal-title":"Cancer"},{"key":"BFleu2012259_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/ageing\/25.5.357","volume":"25","author":"J Blad\u00e9","year":"1996","unstructured":"Blad\u00e9 J, Mu\u00f1oz M, Fontanillas M, San Miguel J, Alcal\u00e1 A, Maldonado J et al. Treatment of multiple myeloma in elderly people: long-term results in 178 patients. Age Ageing 1996; 25: 357\u2013361.","journal-title":"Age Ageing"},{"key":"BFleu2012259_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0609.2001.00301.x","volume":"66","author":"P Rodon","year":"2001","unstructured":"Rodon P, Linassier C, Gauvain JB, Benboubker L, Goupille P, Maigre M et al. Multiple myeloma in elderly patients: presenting features and outcome. Eur J Haematol 2001; 66: 11\u201317.","journal-title":"Eur J Haematol"},{"key":"BFleu2012259_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1600-0609.2005.00532.x","volume":"75","author":"A Anagnostopoulos","year":"2005","unstructured":"Anagnostopoulos A, Gika D, Symeonidis A, Zervas K, Pouli A, Repoussis P et al. Multiple myeloma in elderly patients: prognostic factors and outcome. Eur J Haematol 2005; 75: 370\u2013375.","journal-title":"Eur J Haematol"},{"key":"BFleu2012259_CR8","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1200\/JCO.2008.21.0948","volume":"27","author":"C Hulin","year":"2009","unstructured":"Hulin C, Facon T, Rodon P, Pegourie B, Benboubker L, Doyen C et al. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01\/01 trial. J Clin Oncol 2009; 27: 3664\u20133670.","journal-title":"J Clin Oncol"},{"key":"BFleu2012259_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Rajkumar SV . Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23: 3\u20139.","journal-title":"Leukemia"},{"key":"BFleu2012259_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1634\/theoncologist.9-3-343","volume":"9","author":"RT Penson","year":"2004","unstructured":"Penson RT, Daniels KJ, Lynch TJ . Too old to care? Oncologist 2004; 9: 343\u2013352.","journal-title":"Oncologist"},{"key":"BFleu2012259_CR11","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/jnci\/86.23.1766","volume":"86","author":"SB Yellen","year":"1994","unstructured":"Yellen SB, Cella DF, Leslie WT . Age and clinical decision making in oncology patients. J Natl Cancer Inst 1994; 86: 1766\u20131770.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2012259_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7326\/0003-4819-86-1-117_2","volume":"86","author":"V Clough","year":"1977","unstructured":"Clough V, Delamore IW, Whittaker JA . Multiple myeloma in a young woman. Ann Intern Med 1977; 86: 117\u2013118.","journal-title":"Ann Intern Med"},{"key":"BFleu2012259_CR13","first-page":"104","volume":"46","author":"JM Khunger","year":"2003","unstructured":"Khunger JM, Sharma M, Talib VH . Multiple myeloma presenting as primary non-secretory plasma cell leukemia. Indian J Pathol Microbiol 2003; 46: 104\u2013105.","journal-title":"Indian J Pathol Microbiol"},{"key":"BFleu2012259_CR14","first-page":"177","volume":"66","author":"CC Chen","year":"2003","unstructured":"Chen CC, Gau JP, Ho CH, Lin JS, Chiou HJ, Lirng JF . Aggressive multiple myeloma with brain involvement in a young patient. J Chin Med Assoc 2003; 66: 177\u2013180.","journal-title":"J Chin Med Assoc"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012259","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:08:24Z","timestamp":1648739304000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012259"}},"issued":{"date-parts":[[2012,9,5]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFleu2012259"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.259","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2012,9,5]]},"assertion":[{"value":"5 September 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]},{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T07:54:42Z","timestamp":1722844482378},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/leu.2009.5","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T13:02:01Z","timestamp":1234443721000},"page":"1174-1176","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypermethylation of Death-Associated Protein Kinase 1 differentiates natural killer cell lines from cell lines derived from T-acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"23","author":[{"given":"S","family":"R\u00f6hrs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Zaborski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H G","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Quentmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"BFleu20095_CR1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0145-2126(03)00024-9","volume":"27","author":"Y Matsuo","year":"2003","unstructured":"Matsuo Y, Drexler HG . Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Leuk Res 2003; 27: 935\u2013945.","journal-title":"Leuk Res"},{"key":"BFleu20095_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1749-0774.2004.tb00079.x","volume":"17","author":"Y Matsuo","year":"2004","unstructured":"Matsuo Y, Drexler HG, Harashima A, Okochi A, Shimizu N, Orita K . Transcription factor expression in cell lines derived from natural killer-cell and natural-killer T-cell leukemia-lymphoma. Hum Cell 2004; 17: 85\u201392.","journal-title":"Hum Cell"},{"key":"BFleu20095_CR3","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1093\/nar\/gni127","volume":"33","author":"AOH Nygren","year":"2005","unstructured":"Nygren AOH, Ameziane N, Duarte HMB, Vijzelaar RNCP, Waisfisz Q, Hess CJ et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005; 33: e128.","journal-title":"Nucleic Acids Res"},{"key":"BFleu20095_CR4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M . Epigenetics in cancer. N Engl J Med 2008; 358: 1148\u20131159.","journal-title":"N Engl J Med"},{"key":"BFleu20095_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/72785","volume":"25","author":"JF Costello","year":"2000","unstructured":"Costello JF, Fr\u00fchwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 25: 132\u2013138.","journal-title":"Nat Genet"},{"key":"BFleu20095_CR6","first-page":"3225","volume":"61","author":"M Esteller","year":"2001","unstructured":"Esteller M, Corn PG, Baylin SB, Herman JG . A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225\u20133229.","journal-title":"Cancer Res"},{"key":"BFleu20095_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1521-6616(03)00208-0","volume":"109","author":"M Esteller","year":"2003","unstructured":"Esteller M . Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol 2003; 109: 80\u201388.","journal-title":"Clin Immunol"},{"key":"BFleu20095_CR8","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/sj.leu.2404345","volume":"10","author":"FB Rahmatpanah","year":"2006","unstructured":"Rahmatpanah FB, Carstens S, Guo J, Sjahputera O, Taylor KH, Duft D et al. Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior. Leukemia 2006; 10: 1855\u20131862.","journal-title":"Leukemia"},{"key":"BFleu20095_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/carcin\/bgl092","volume":"28","author":"H Shi","year":"2007","unstructured":"Shi H, Guo J, Duff DJ, Rahmatpanah FB, Chitima-Matsiga R, Al-Kuhlani M et al. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 2007; 28: 60\u201370.","journal-title":"Carcinogenesis"},{"key":"BFleu20095_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1101\/gad.9.1.15","volume":"9","author":"LP Deiss","year":"1995","unstructured":"Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A . Identification of a novel serine\/threonine kinase and a novel 15-kD protein as potential mediators of the \u03b3 interferon-induced cell death. Genes Dev 1995; 9: 15\u201330.","journal-title":"Genes Dev"},{"key":"BFleu20095_CR11","first-page":"141","volume":"146","author":"O Cohen","year":"1999","unstructured":"Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T et al. DAP-Kinase participates in TNF- and RAS-induced apoptosis and its function requires the death domain. J Cell Biol 1999; 146: 141\u2013148.","journal-title":"J Cell Biol"},{"key":"BFleu20095_CR12","volume-title":"Guide to Leukemia-Lymphoma Cell Lines","author":"HG Drexler","year":"2005","unstructured":"Drexler HG . Guide to Leukemia-Lymphoma Cell Lines. Braunschweig, 2005."},{"key":"BFleu20095_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1349-7006.2003.tb01357.x","volume":"94","author":"S Nakatsuka","year":"2003","unstructured":"Nakatsuka S, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, Yamaguchi M et al. Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)\/T-cell malignancies. Cancer Sci 2003; 94: 87\u201391.","journal-title":"Cancer Sci"},{"key":"BFleu20095_CR14","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1200\/JCO.2005.01.4944","volume":"23","author":"J Roman-Gomez","year":"2005","unstructured":"Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A . Lack of CpG Island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 2005; 23: 7043\u20137049.","journal-title":"J Clin Oncol"},{"key":"BFleu20095_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0959-437X(95)80044-1","volume":"5","author":"SH Cross","year":"1995","unstructured":"Cross SH, Bird AP . CpG islands and genes. Curr Opin Genet Dev 1995; 5: 309\u2013314.","journal-title":"Curr Opin Genet Dev"},{"key":"BFleu20095_CR16","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","volume":"21","author":"M Esteller","year":"2002","unstructured":"Esteller M . CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21: 5427\u20135440.","journal-title":"Oncogene"},{"key":"BFleu20095_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1101\/gad.1632208","volume":"22","author":"LA Puto","year":"2008","unstructured":"Puto LA, Reed JC . Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev 2008; 22: 998\u20131010.","journal-title":"Genes Dev"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu20095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu20095","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu20095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:34:13Z","timestamp":1648730053000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu20095"}},"issued":{"date-parts":[[2009,2,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFleu20095"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.5","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2009,2,12]]},"assertion":[{"value":"12 February 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:51:30Z","timestamp":1694623890841},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T00:00:00Z","timestamp":1107388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T00:00:00Z","timestamp":1107388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1038\/sj.leu.2403659","type":"journal-article","created":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T10:25:35Z","timestamp":1107426335000},"page":"326-328","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and biological features of favorable-risk acute myelogenous leukemia \u2013 is favorable-risk AML really favorable?"],"prefix":"10.1038","volume":"19","author":[{"given":"G J","family":"Schiller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,3]]},"reference":[{"key":"BF2403659_CR1","first-page":"4173","volume":"58","author":"CD Bloomfield","year":"1998","unstructured":"Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 1998; 58: 4173\u20134179.","journal-title":"Cancer Res"},{"key":"BF2403659_CR2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","volume":"92","author":"D Grimwade","year":"1998","unstructured":"Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al., on behalf of the Medical Research Council Adult and Children's Leukemia Working Parties. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322\u20132333.","journal-title":"Blood"},{"key":"BF2403659_CR3","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","volume":"96","author":"ML Slovak","year":"2000","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a southwest Oncology Group\/Eastern Cooperative Oncology Group study. Blood 2000; 96: 4075\u20134083.","journal-title":"Blood"},{"key":"BF2403659_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.leu.2403187","volume":"18","author":"C Schoch","year":"2004","unstructured":"Schoch C, Kern W, Schnittger S, Hiddemann W, Haferlach T . Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004; 18: 120\u2013125.","journal-title":"Leukemia"},{"key":"BF2403659_CR5","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1182\/blood-2002-02-0632","volume":"100","author":"MS Tallman","year":"2002","unstructured":"Tallman MS, Antersen JW, Schiffer CA, Appelbaum RR, Feusner JH, Woods WG et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 2002; 100: 4296\u20134302.","journal-title":"Blood"},{"key":"BF2403659_CR6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V76.6.1083.1083","volume":"76","author":"J Pedersen-Bjergaard","year":"1990","unstructured":"Pedersen-Bjergaard J, Philip P, Qlesen L, Jensen G, Byrsting K . Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 76: 1083\u20131091.","journal-title":"Blood"},{"key":"BF2403659_CR7","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoeitic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoeitic and Lymphoid Tissues. Lyon, France: IARC Press, 2001."},{"key":"BF2403659_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJM198309153091103","volume":"309","author":"MM Le Beau","year":"1983","unstructured":"Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD . Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic\u2013clinicopathological association. N Engl J Med 1983; 309: 630\u2013636.","journal-title":"N Engl J Med"},{"key":"BF2403659_CR9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1182\/blood.V68.6.1242.1242","volume":"68","author":"RA Larson","year":"1986","unstructured":"Larson RA, Williams SF, Le Beau MM, Bitter MA, Vardiman JW, Rowley JD . Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood 1986; 68: 1242\u20131249.","journal-title":"Blood"},{"key":"BF2403659_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0165-4608(83)90050-X","volume":"10","author":"RA Larson","year":"1983","unstructured":"Larson RA, Le Beau MM, Vardiman JW, Testa JR, Golomb HM, Rowley JD . The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970\u20131982). Cancer Genet Cytogenet 1983; 10: 219\u2013236.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2403659_CR11","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mr\u00f3zek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325\u20134336.","journal-title":"Blood"},{"key":"BF2403659_CR12","first-page":"122","volume":"27","author":"JD Rowley","year":"1990","unstructured":"Rowley JD . Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 1990; 27: 122\u2013136.","journal-title":"Semin Hematol"},{"key":"BF2403659_CR13","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/sj.leu.2403009","volume":"17","author":"RF Schlenk","year":"2003","unstructured":"Schlenk RF, Benner A, Hartmann F, del Valle F, Weber C, Pralle H, et al., AML Study Group Ulm (AMLSG ULM). Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Leukemia 2003; 17: 1521\u20131528.","journal-title":"Leukemia"},{"key":"BF2403659_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1200\/JCO.2004.07.012","volume":"22","author":"JC Byrd","year":"2004","unstructured":"Byrd JC, Ruppert AS, Mr\u00f3zek K, Carroll AJ, Edwards CG, Arthur DC et al. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461. J Clin Oncol 2004; 22: 1087\u20131094.","journal-title":"J Clin Oncol"},{"key":"BF2403659_CR15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood.V77.7.1429.1429","volume":"77","author":"GL Phillips","year":"1991","unstructured":"Phillips GL, Reece DE, Shepherd JD, Barnett MJ, Brown RA, Frei-Lahr DA et al. High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults. Blood 1991; 77: 1429\u20131435.","journal-title":"Blood"},{"key":"BF2403659_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","volume":"98","author":"D Grimwade","year":"2001","unstructured":"Grimwade D, Walder H, Harrison G, Oliver F, Chatters S, Harrison CJ, et al., on behalf of the Medical Research Council Adult Leukaemia Working Party. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001; 98: 1312\u20131320.","journal-title":"Blood"},{"key":"BF2403659_CR17","first-page":"2931","volume":"90","author":"A Ferrant","year":"1997","unstructured":"Ferrant A, Frassoni LF, Prentice HG, Cahn JY, Blaise D, Reiffers J, et al., on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Blood 1997; 90: 2931\u20132938.","journal-title":"Blood"},{"key":"BF2403659_CR18","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bbmt.2003.08.004","volume":"9","author":"HC Fung","year":"2003","unstructured":"Fung HC, Stein A, Slovak ML, O\u2019Donnell MR, Snyder DS, Cohen S et al. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant 2003; 9: 766\u2013771.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2403659_CR19","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V85.9.2289.bloodjournal8592289","volume":"85","author":"PP Liu","year":"1995","unstructured":"Liu PP, Hajra A, Wijmenga C, Collins FS . Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995; 85: 2289\u20132302.","journal-title":"Blood"},{"key":"BF2403659_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1200\/JCO.2004.06.060","volume":"22","author":"S Fr\u00f6hling","year":"2004","unstructured":"Fr\u00f6hling S, Schlenk RF, Stolze I, Bihlmayr J, Benner A, Kreitmeier S et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 2004; 22: 624\u2013633.","journal-title":"J Clin Oncol"},{"key":"BF2403659_CR21","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood.V92.8.2879","volume":"92","author":"D Roulston","year":"1998","unstructured":"Roulston D, Espinosa III R, Nucifora G, Larson RA, Le Beau MM, Rowley JD . CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 1998; 92: 2879\u20132885.","journal-title":"Blood"},{"key":"BF2403659_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1034\/j.1600-0609.2003.00131.x","volume":"71","author":"G Marcucci","year":"2003","unstructured":"Marcucci G, Caligiuri MA, Bloomfield CD . Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically. Eur J Haematol 2003; 71: 143\u2013154.","journal-title":"Eur J Haematol"},{"key":"BF2403659_CR23","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1200\/JCO.1999.17.12.3767","volume":"17","author":"JC Byrd","year":"1999","unstructured":"Byrd JC, Dodge RK, Carroll A, Baer MR, Edwards C, Stamberg J et al. Patients with t(8;21)(q22;22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999; 17: 3767\u20133775.","journal-title":"J Clin Oncol"},{"key":"BF2403659_CR24","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V80.12.2977.2977","volume":"80","author":"G Schiller","year":"1992","unstructured":"Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T et al. Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood 1992; 80: 2977\u20132982.","journal-title":"Blood"},{"key":"BF2403659_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/sj.leu.2403366","volume":"18","author":"J Roche","year":"2004","unstructured":"Roche J, Zeng C, Baron A, Gadgil S, Gemmill RM, Tigaud I et al. Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics. Leukemia 2004; 18: 1059\u20131063.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403659","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:15:30Z","timestamp":1648775730000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403659"}},"issued":{"date-parts":[[2005,2,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"alternative-id":["BF2403659"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403659","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2005,2,3]]},"assertion":[{"value":"6 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T21:27:55Z","timestamp":1722893275914},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[1999,6,1]]},"DOI":"10.1038\/sj.leu.2401402","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T16:23:18Z","timestamp":1294417398000},"page":"983-983","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reply: Immunophenotypic prediction of TEL-AML1 rearrangement in childhood ALL"],"prefix":"10.1038","volume":"13","author":[{"given":"MJ","family":"Borowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Rubnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DJ","family":"Pullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Camitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Pediatric Oncology Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,6,12]]},"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401402","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:11:11Z","timestamp":1648757471000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401402"}},"issued":{"date-parts":[[1999,6,1]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,6,1]]}},"alternative-id":["BF2401402"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401402","ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"published":{"date-parts":[[1999,6,1]]},"assertion":[{"value":"26 January 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 1999","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:27:56Z","timestamp":1694622476676},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T00:00:00Z","timestamp":1076544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T00:00:00Z","timestamp":1076544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1038\/sj.leu.2403311","type":"journal-article","created":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T11:03:04Z","timestamp":1076583784000},"page":"886-887","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Imatinib mesylate associated with delayed hematopoietic recovery after concomitant chemotherapy"],"prefix":"10.1038","volume":"18","author":[{"given":"M","family":"Chand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Thakuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-K","family":"Keung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,2,12]]},"reference":[{"key":"BF2403311_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.leu.2402800","volume":"17","author":"H Ruchatz","year":"2003","unstructured":"Ruchatz H, Puttini M, Cleris L, Pilotti S, Gambacorti-Passerini C, Formelli F . Effect of imatinib on haematopoietic recovery following idarubicin exposure. Leukemia 2003; 17: 298\u2013304.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403311","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:51:15Z","timestamp":1648777875000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403311"}},"issued":{"date-parts":[[2004,2,12]]},"references-count":1,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"alternative-id":["BF2403311"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403311","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2004,2,12]]},"assertion":[{"value":"18 November 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T18:10:17Z","timestamp":1699985417514},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,5,4]],"date-time":"2006-05-04T00:00:00Z","timestamp":1146700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,4]],"date-time":"2006-05-04T00:00:00Z","timestamp":1146700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1038\/sj.leu.2404240","type":"journal-article","created":{"date-parts":[[2006,5,4]],"date-time":"2006-05-04T11:09:35Z","timestamp":1146740975000},"page":"1324-1326","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia"],"prefix":"10.1038","volume":"20","author":[{"given":"N C","family":"Lea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N B","family":"Westwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Arno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"G\u00e4ken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Mohamedali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J","family":"Mufti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,5,4]]},"reference":[{"key":"BF2404240_CR1","first-page":"27","volume-title":"World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of and Lymphoid Tissues","author":"M Imbert","year":"2001","unstructured":"Imbert M, Bain B, Pierre R . Chronic neutrophilic leukaemia. In: Jaffe ES, Harris NL, Stein H et al. (eds). World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of and Lymphoid Tissues. IARC Press: Lyon, 2001, pp. 27\u201328."},{"key":"BF2404240_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2403562","volume":"19","author":"MA Elliot","year":"2005","unstructured":"Elliot MA, Hanson CA, Dewald GW, Smoley SA, Lasho TL, Tefferi A . WHO-defined chronic neutrophilia leukaemia: a long-term analysis of 12 cases and a critical review of the literature. Leukaemia 2005; 19: 313\u2013317.","journal-title":"Leukaemia"},{"key":"BF2404240_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, LeCouedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera. Nature 2005; 434: 1144\u20131148.","journal-title":"Nature"},{"key":"BF2404240_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054\u20131061.","journal-title":"Lancet"},{"key":"BF2404240_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Pssamonti F, Buser A, Soon-Siong Teo BS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779\u20131790.","journal-title":"N Engl J Med"},{"key":"BF2404240_CR6","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","volume":"106","author":"AV Jones","year":"2005","unstructured":"Jones AV, Kriel S, Zoi K, Waghorn K, Curtis C, Zhang L et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162\u20132168.","journal-title":"Blood"},{"key":"BF2404240_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","volume":"106","author":"DP Steensma","year":"2005","unstructured":"Steensma DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u2018atypical\u2019 myeloproliferative disorders and myelodysplastic syndromes. Blood 2005; 106: 1207\u20131209.","journal-title":"Blood"},{"key":"BF2404240_CR8","first-page":"1696","volume":"90","author":"DP McLornan","year":"2005","unstructured":"McLornan DP, Percy MJ, Jones AV, Cross NCP, McMullin MF . Chronic neutrophilic leukaemia with an associated V617F Jak2 tyrosine kinase mutation. Haematologica 2005; 90: 1696\u20131697.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404240","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:31:49Z","timestamp":1648780309000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404240"}},"issued":{"date-parts":[[2006,5,4]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["BF2404240"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404240","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2006,5,4]]},"assertion":[{"value":"4 May 2006","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T21:39:15Z","timestamp":1697665155047},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T00:00:00Z","timestamp":1190246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T00:00:00Z","timestamp":1190246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/sj.leu.2404954","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T11:31:04Z","timestamp":1190287864000},"page":"861-864","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clonal expansion of non-leukemic cells expressing two novel MLL\u2013ELL variants differing in transforming activity"],"prefix":"10.1038","volume":"22","author":[{"given":"M","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Nakaseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Ohwada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,20]]},"reference":[{"key":"BF2404954_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semcancer.2005.01.007","volume":"15","author":"A Daser","year":"2005","unstructured":"Daser A, Rabbitts TH . The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol 2005; 15: 175\u2013188.","journal-title":"Semin Cancer Biol"},{"key":"BF2404954_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.leu.2404150","volume":"20","author":"C Meyer","year":"2006","unstructured":"Meyer C, Schneider B, Jakob S, Strehl S, Attarbaschi A, Schnittger S et al. The MLL recombinome of acute leukemias. Leukemia 2006; 20: 777\u2013784.","journal-title":"Leukemia"},{"key":"BF2404954_CR3","doi-asserted-by":"publisher","first-page":"12110","DOI":"10.1073\/pnas.91.25.12110","volume":"91","author":"MJ Thirman","year":"1994","unstructured":"Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD . Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994; 91: 12110\u201312114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404954_CR4","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.1073\/pnas.190167297","volume":"97","author":"C Lavau","year":"2000","unstructured":"Lavau C, Luo RT, Du C, Thirman MJ . Retrovirus-mediated gene transfer of MLL\u2013ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci USA 2000; 97: 10984\u201310989.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404954_CR5","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-05-1691","volume":"65","author":"SJ Horton","year":"2005","unstructured":"Horton SJ, Grier DG, McGonigle GJ, Thompson A, Morrow M, De Silva I et al. Continuous MLL\u2013ENL expression is necessary to establish a \u2018Hox Code\u2019 and maintain immortalization of hematopoietic progenitor cells. Cancer Res 2005; 65: 9245\u20139252.","journal-title":"Cancer Res"},{"key":"BF2404954_CR6","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1182\/blood-2005-01-0286","volume":"105","author":"O Teuffel","year":"2005","unstructured":"Teuffel O, Betts DR, Thali M, Eberle D, Meyer C, Schneider B et al. Clonal expansion of a new MLL rearrangement in the absence of leukemia. Blood 2005; 105: 4151\u20134152.","journal-title":"Blood"},{"key":"BF2404954_CR7","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.V87.5.1912.1912","volume":"87","author":"PL Broeker","year":"1996","unstructured":"Broeker PL, Super HG, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S et al. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 1996; 87: 1912\u20131922.","journal-title":"Blood"},{"key":"BF2404954_CR8","first-page":"2171","volume":"56","author":"K Lochner","year":"1996","unstructured":"Lochner K, Siegler G, Fuhrer M, Greil J, Beck JD, Fey GH et al. A specific deletion in the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias. Cancer Res 1996; 56: 2171\u20132177.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404954","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:21:34Z","timestamp":1648779694000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404954"}},"issued":{"date-parts":[[2007,9,20]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BF2404954"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404954","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2007,9,20]]},"assertion":[{"value":"20 September 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:02:36Z","timestamp":1694620956044},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[1997,5,1]]},"DOI":"10.1038\/sj.leu.2400636","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:22:28Z","timestamp":1031163748000},"page":"619-623","source":"Crossref","is-referenced-by-count":1,"title":["Fre2, a proviral integration site of Friend murine leukemia virus that is closely linked to Fv2"],"prefix":"10.1038","volume":"11","author":[{"given":"RW","family":"Friedrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Veit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Eisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Pass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CA","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2400636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2400636","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2400636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:07:21Z","timestamp":1648750041000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2400636"}},"issued":{"date-parts":[[1997,5,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,5,1]]}},"alternative-id":["BF2400636"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2400636","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[1997,5,1]]}},{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:52:36Z","timestamp":1694623956110},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T00:00:00Z","timestamp":1106179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T00:00:00Z","timestamp":1106179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1038\/sj.leu.2403637","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T22:01:23Z","timestamp":1106776883000},"page":"335-335","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical\u2013biological situations"],"prefix":"10.1038","volume":"19","author":[{"given":"Thomas","family":"Lion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Muller-B\u00e9rat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,20]]},"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403637","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:16:56Z","timestamp":1648775816000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403637"}},"issued":{"date-parts":[[2005,1,20]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"alternative-id":["BF2403637"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403637","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2005,1,20]]},"assertion":[{"value":"20 January 2005","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T02:23:16Z","timestamp":1697163796736},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"DOI":"10.1038\/sj\/leu\/2401338","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:59:08Z","timestamp":1027673948000},"page":"369-375","source":"Crossref","is-referenced-by-count":2,"title":["True"],"prefix":"10.1038","volume":"13","member":"297","published-online":{"date-parts":[[1999,3,10]]},"container-title":["Leukemia"],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T02:47:12Z","timestamp":1684810032000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/doifinder\/10.1038\/sj\/leu\/2401338"}},"issued":{"date-parts":[[1999]]},"references-count":0,"journal-issue":{"issue":"3"},"alternative-id":["2401338"],"URL":"https:\/\/doi.org\/10.1038\/sj\/leu\/2401338","ISSN":["0887-6924"],"issn-type":[{"value":"0887-6924","type":"electronic"}],"published-other":{"date-parts":[[1999]]},"published":{"date-parts":[[1999]]}},{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:05:07Z","timestamp":1700226307142},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,9,1]]},"DOI":"10.1038\/sj.leu.2403050","type":"journal-article","created":{"date-parts":[[2003,9,11]],"date-time":"2003-09-11T14:47:26Z","timestamp":1063291646000},"page":"1916-1917","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation"],"prefix":"10.1038","volume":"17","author":[{"given":"A","family":"Grigg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kimber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Szer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,9,10]]},"reference":[{"key":"BF2403050_CR1","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/sj.leu.2402716","volume":"16","author":"A Tedeschi","year":"2002","unstructured":"Tedeschi A, Cairoli R, Marenco P, Nosari A, Tresoldi E et al. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation. Leukemia 2002; 16: 2455\u20132456.","journal-title":"Leukemia"},{"key":"BF2403050_CR2","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1182\/blood-2002-02-0352","volume":"100","author":"G Avvisati","year":"2002","unstructured":"Avvisati G, Petti MC, Lo-Coco F, Vegna ML, Amadori S, Baccarani M et al. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. Blood 2002; 100: 3141\u20133146.","journal-title":"Blood"},{"key":"BF2403050_CR3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood.V92.3.784","volume":"92","author":"D Diverio","year":"1998","unstructured":"Diverio D, Rossi V, Avvisati G, De Santis S, Pistilli A, Pane F et al. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML\/RAR\u03b1 fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicentre \u2018AIDA\u2019 trial. Blood 1998; 92: 784\u2013789.","journal-title":"Blood"},{"key":"BF2403050_CR4","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1182\/blood.V94.7.2225.419k03_2225_2229","volume":"94","author":"F Lo Coco","year":"1999","unstructured":"Lo Coco F, Diverio D, Avvisati G, Petti MC, Meloni G, Pogliani EM et al. Therapy of molecular relapse in acute promyelocytic leukemia. Blood 1999; 94: 2225\u20132229.","journal-title":"Blood"},{"key":"BF2403050_CR5","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/clinchem\/48.10.1858","volume":"48","author":"TL Applegate","year":"2002","unstructured":"Applegate TL, Iland HJ, Mokany E, Todd AV . Molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR. Clin Chem 2002; 48: 1858\u20131860.","journal-title":"Clin Chem"},{"key":"BF2403050_CR6","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","volume":"19","author":"SL Soignet","year":"2001","unstructured":"Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001; 19: 3852\u20133860.","journal-title":"J Clin Oncol"},{"key":"BF2403050_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.189.7.1043","volume":"189","author":"V Lallemand-Breitenbach","year":"1999","unstructured":"Lallemand-Breitenbach V, Guillemin MC, Janin A, Daniel MT, Degos L, Kogan SC et al. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med 1999; 189: 1043\u20131052.","journal-title":"J Exp Med"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403050","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:56:53Z","timestamp":1648778213000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403050"}},"issued":{"date-parts":[[2003,9,1]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9,1]]}},"alternative-id":["BF2403050"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403050","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2003,9,1]]},"assertion":[{"value":"10 September 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:57:51Z","timestamp":1697457471989},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[1998,12,1]]},"DOI":"10.1038\/sj.leu.2401209","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:25:00Z","timestamp":1031163900000},"page":"2034-2035","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of a novel CBFB-MYH11 fusion transcript in a patient with AML and inversion of chromosome 16"],"prefix":"10.1038","volume":"12","author":[{"given":"FH","family":"Springall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RL","family":"Lukeis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DE","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HJ","family":"Iland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1998,12,8]]},"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401209","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:10:06Z","timestamp":1648757406000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401209"}},"issued":{"date-parts":[[1998,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1998,12,1]]}},"alternative-id":["BF2401209"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401209","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[1998,12,1]]},"assertion":[{"value":"22 May 1998","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 1998","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 1998","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:21:12Z","timestamp":1683174072284},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T00:00:00Z","timestamp":1123718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T00:00:00Z","timestamp":1123718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1038\/sj.leu.2403908","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T11:53:00Z","timestamp":1123761180000},"page":"1857-1857","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reply to \u2018NK cell subsets and CD107a mobilization assay\u2019 by Zimmer et al"],"prefix":"10.1038","volume":"19","author":[{"given":"O","family":"Penack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Gentilini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Asemissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Uharek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,11]]},"reference":[{"key":"BF2403908_CR1","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/sj.leu.2403906","volume":"19","author":"J Zimmer","year":"2005","unstructured":"Zimmer J, Andres A, Hentges P . NK cell subsets and CD107a mobilization assay. Leukemia 2005; 19: 1850\u20131851.","journal-title":"Leukemia"},{"key":"BF2403908_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/sj.leu.2403704","volume":"19","author":"O Penack","year":"2005","unstructured":"Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, Thiel E et al. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 2005; 19: 835\u2013840.","journal-title":"Leukemia"},{"key":"BF2403908_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","volume":"294","author":"G Alter","year":"2004","unstructured":"Alter G, Malenfant JM, Altfeld M . CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15\u201322.","journal-title":"J Immunol Methods"},{"key":"BF2403908_CR4","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.4049\/jimmunol.173.8.5305","volume":"173","author":"G Alter","year":"2004","unstructured":"Alter G, Malenfant JM, Delabre RM, Burgett NC, Yu XG, Lichterfeld M et al. Increased natural killer cell activity in viremic HIV-1 infection. J Immunol 2004; 173: 5305\u20135311.","journal-title":"J Immunol"},{"key":"BF2403908_CR5","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.4049\/jimmunol.136.12.4480","volume":"136","author":"LL Lanier","year":"1986","unstructured":"Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH . The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136: 4480\u20134486.","journal-title":"J Immunol"},{"key":"BF2403908_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1084\/jem.164.1.351","volume":"164","author":"RE Schmidt","year":"1986","unstructured":"Schmidt RE, Murray C, Daley JF, Schlossman SF, Ritz J . A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med 1986; 164: 351\u2013356.","journal-title":"J Exp Med"},{"key":"BF2403908_CR7","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.143.10.3183","volume":"143","author":"A Nagler","year":"1989","unstructured":"Nagler A, Lanier LL, Cwirla S, Phillips JH . Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143: 3183\u20133191.","journal-title":"J Immunol"},{"key":"BF2403908_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0171-2985(11)80315-3","volume":"185","author":"P Uciechowski","year":"1992","unstructured":"Uciechowski P, Werfel T, Leo R, Gessner JE, Schubert J, Schmidt RE . Analysis of CD16+dim and CD16+bright lymphocytes\u2013comparison of peripheral and clonal non-MHC-restricted T cells and NK cells. Immunobiology 1992; 185: 28\u201340.","journal-title":"Immunobiology"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403908","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T03:29:57Z","timestamp":1683170997000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403908"}},"issued":{"date-parts":[[2005,8,11]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10,1]]}},"alternative-id":["BF2403908"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403908","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2005,8,11]]},"assertion":[{"value":"27 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:55:47Z","timestamp":1694627747172},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T00:00:00Z","timestamp":1160611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T00:00:00Z","timestamp":1160611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1038\/sj.leu.2404422","type":"journal-article","created":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T15:38:33Z","timestamp":1160667513000},"page":"2182-2184","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibody-mediated targeting of viral vectors to the Fc receptor expressed on acute myeloid leukemia cells"],"prefix":"10.1038","volume":"20","author":[{"given":"T","family":"W\u00fcrdinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Verheije","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L M","family":"van der Aa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B J","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C A M","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V W","family":"van Beusechem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W R","family":"Gerritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J M","family":"Rottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,10,12]]},"reference":[{"key":"BF2404422_CR1","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/sj.leu.2402582","volume":"16","author":"RC Koya","year":"2002","unstructured":"Koya RC, Kasahara N, Pullarkat V, Levine AM, Stripecke R . Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses. Leukemia 2002; 16: 1645\u20131654.","journal-title":"Leukemia"},{"key":"BF2404422_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/rmv.405","volume":"13","author":"A Takada","year":"2003","unstructured":"Takada A, Kawaoka Y . Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 2003; 13: 387\u2013398.","journal-title":"Rev Med Virol"},{"key":"BF2404422_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/jlb.55.6.816","volume":"55","author":"PK Wallace","year":"1994","unstructured":"Wallace PK, Howell AL, Fanger MW . Role of Fc gamma receptors in cancer and infectious disease. J Leukoc Biol 1994; 55: 816\u2013826.","journal-title":"J Leukoc Biol"},{"key":"BF2404422_CR4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/sj.gt.3302535","volume":"12","author":"T W\u00fcrdinger","year":"2005","unstructured":"W\u00fcrdinger T, Verheije MH, Raaben M, Bosch BJ, de Haan CAM, van Beusechem VW et al. Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody. Gene Therapy 2005; 12: 1394\u20131404.","journal-title":"Gene Therapy"},{"key":"BF2404422_CR5","doi-asserted-by":"publisher","first-page":"15314","DOI":"10.1128\/JVI.79.24.15314-15322.2005","volume":"79","author":"T Wurdinger","year":"2005","unstructured":"Wurdinger T, Verheije MH, Broen K, Bosch BJ, de Haan CAM, van Beusechem VW et al. Soluble receptor-mediated targeting of mouse hepatitis coronavirus to the human epidermal growth factor receptor. J Virol 2005; 79: 15314\u201315322.","journal-title":"J Virol"},{"key":"BF2404422_CR6","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1128\/JVI.80.3.1250-1260.2006","volume":"80","author":"MH Verheije","year":"2006","unstructured":"Verheije MH, Wurdinger T, van Beusechem VW, de Haan CAM, Gerritsen WR, Rottier PJM . Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter. J Virol 2006; 80: 1250\u20131260.","journal-title":"J Virol"},{"key":"BF2404422_CR7","doi-asserted-by":"publisher","first-page":"11123","DOI":"10.1128\/JVI.77.21.11312-11323.2003","volume":"77","author":"CAM de Haan","year":"2003","unstructured":"de Haan CAM, van Genne L, Stoop JN, Volders H, Rottier PJM . Coronaviruses as vectors: position dependence of foreign gene expression. J Virol 2003; 77: 11123\u201311312.","journal-title":"J Virol"},{"key":"BF2404422_CR8","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/jvi.71.4.3129-3137.1997","volume":"71","author":"TM Gallagher","year":"1997","unstructured":"Gallagher TM . A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J Virol 1997; 71: 3129\u20133137.","journal-title":"J Virol"},{"key":"BF2404422_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3181\/00379727-185-42532","volume":"185","author":"W Gilmore","year":"1987","unstructured":"Gilmore W, Fleming JO, Stohlman SA, Weiner LP . Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies. Proc Soc Exp Biol Med 1987; 185: 177\u2013186.","journal-title":"Proc Soc Exp Biol Med"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404422","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:33:59Z","timestamp":1648784039000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404422"}},"issued":{"date-parts":[[2006,10,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12,1]]}},"alternative-id":["BF2404422"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404422","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2006,10,12]]},"assertion":[{"value":"12 October 2006","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}